Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

977
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
977
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.1K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.1K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.7K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.7K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

3.5K
The pathophysiology of pneumonia involves the following steps:
3.5K
Pneumonia IV: Management01:28

Pneumonia IV: Management

890
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
890
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How much should we sequence? An analysis of the Swiss SARS-CoV-2 surveillance effort.

Microbiology spectrum·2024
Same author

[False positives in infectious serology : a rare issue that should not be ignored].

Revue medicale suisse·2023
Same author

IVDR: Analysis of the Social, Economic, and Practical Consequences of the Application of an Ordinance of the In Vitro Diagnostic Ordinance in Switzerland.

Diagnostics (Basel, Switzerland)·2023
Same author

Venous thromboembolism in critically Ill patients with COVID-19: Results of a screening study for deep vein thrombosis.

Research and practice in thrombosis and haemostasis·2020
Same author

Transverse myelitis related to COVID-19 infection.

Journal of neurology·2020
Same author

[Management of acute diarrhea].

Revue medicale suisse·2018

Related Experiment Video

Updated: Feb 27, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

2.9K

[Mycoplasma pneumoniae: update and new challenges].

Alexis Dumoulin1

  • 1Biologiste adjoint, Service des maladies infectieuses, Institut central des Hôpitaux, Hôpital du Valais, Avenue du Grand-Champsec 86, 1950 Sion.

Revue Medicale Suisse
|July 8, 2017
PubMed
Summary

Mycoplasma pneumoniae causes community-acquired pneumonia and complications. Diagnosis is challenging due to difficult culture, persistent antibodies, and emerging macrolide resistance in this common childhood pathogen.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pediatrics

Background:

  • Mycoplasma pneumoniae is a significant cause of community-acquired pneumonia, particularly in children.
  • Historically misclassified as a virus due to cultivation difficulties.
  • Associated with diverse and severe complications, including neurological and dermatological issues.

Purpose of the Study:

  • To highlight the diagnostic challenges associated with Mycoplasma pneumoniae.
  • To underscore the impact of macrolide-resistant strains.
  • To provide an overview of the pathogen's clinical significance.

Main Methods:

  • Review of Mycoplasma pneumoniae characteristics and clinical impact.
  • Discussion of diagnostic limitations: culture, serology, and carrier state.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K
Optimized PCR-based Detection of Mycoplasma
06:01

Optimized PCR-based Detection of Mycoplasma

Published on: June 20, 2011

55.2K

Related Experiment Videos

Last Updated: Feb 27, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

2.9K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K
Optimized PCR-based Detection of Mycoplasma
06:01

Optimized PCR-based Detection of Mycoplasma

Published on: June 20, 2011

55.2K
  • Analysis of emerging macrolide resistance.

    • Main Results:

    • Laboratory diagnosis is complicated by fastidious growth, persistent IgM, and uncertain asymptomatic carriage.
    • Macrolide-resistant Mycoplasma pneumoniae strains present a growing clinical challenge.
    • The pathogen causes significant morbidity, including severe complications.

    Conclusions:

    • Accurate and timely diagnosis of Mycoplasma pneumoniae remains difficult.
    • Macrolide resistance necessitates careful treatment strategies.
    • Further research is needed to address diagnostic and therapeutic challenges.